XML 111 R84.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION - SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS AND STOCK APPRECIATION RIGHTS AWARD ACTIVITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 40.74 $ 42.19 $ 41.54  
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 138,896 148,508 149,320 114,520
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 62.80 $ 76.63 $ 47.00  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Stock-settled appreciation rights granted 44,144 39,978 91,768  
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 18.38 $ 20.52 $ 12.88  
Share Based Compensation Arrangements By Share Based Payment Award, Options and Stock Appreciation Rights Outstanding [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 192,700 495,181 526,818  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 203,320 161,506 310,715  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 68.69 $ 66.06 $ 63.71  
Weighted Average Remaining Contractual Term, Outstanding 6 years 1 month      
Weighted Average Remaining Contractual Term, Exercisable 4 years 7 months      
Aggregate Intrinsic Value, Outstanding $ 6,514      
Aggregate Intrinsic Value, Exercisable $ 5,623      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,453,932 1,331,580 1,549,350  
Stock-settled appreciation rights granted 509,046 455,807 709,999  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price $ 57.93 $ 56.96 $ 53.35  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 59.26 $ 57.75 $ 52.62 $ 54.47
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 2,351,633 2,238,607 2,439,487 2,567,021
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 62.68 $ 71.21 $ 42.63  
Share-based Compensation Award, Tranche Two [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 90,798      
Share-based Compensation Award, Tranche Two [Member] | Net Income Growth Rate [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 48,098